Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-mFBG PET Imaging in Neuroblastoma
NCT04724369Phase 3Completed
- Sponsor
- Innervate Radiopharmaceuticals
- Start
- Nov 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of florbenguane F-18 in neuroblastoma, sponsored by Innervate Radiopharmaceuticals. Started Nov 2021; status: completed.
02
Drugs
florbenguane F-18
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT04724369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724369.